Some people with type 2 diabetes might have trouble hitting their health targets, despite lifestyle changes and taking GLP-1 medications. GLP-1 medications like Ozempic and Mounjaro can lead to weight ...

Microdosing is the off-label use of GLP-1 receptor agonists at doses lower than those approved for the treatment of diabetes or obesity. There are numerous reasons people may explore microdosing, ...

U.S. News & World Report has released its 2025 list of best diets, including top-ranked diets for people with diabetes. The list includes nutritious eating patterns such as the Mediterranean diet, the ...

Liver disease can progress for years without symptoms, so it’s essential to stay up-to-date on your blood tests and get liver scans when appropriate. Liver disease affects many people with diabetes, ...

Editor's note: Some of the terms around this topic may be new or unfamiliar. Jump to the end of the article for a few helpful definitions. Claire Hinkle shares her experience coming out as transgender ...

From navigating the healthcare system to figuring out how to manage diabetes medications while on gender-affirming hormone therapy, being a transgender person with diabetes comes with additional ...

This lettuce-wrapped smash-and-fry burger recipe is diabetes-friendly and has only 3 grams of carbs per serving. As anyone who is avoiding carbs or gluten already knows, a burger wrapped in a single ...

For people seeking an oral GLP-1 medication, Foundayo is now available in the U.S. The latest weight management medication on the market, Eli Lilly’s Foundayo (orforglipron), was approved by the FDA ...

High blood sugar at night – and in the morning – can be caused by meal and insulin timing, along with hormonal effects like the dawn phenomenon. Automated insulin delivery (AID) can help manage ...

GLP-1-based medications have revolutionized blood sugar and weight management, but they aren’t effective for everyone. Eli Lilly, which makes the GLP-1/GIP drug Mounjaro (tirzepatide), is currently ...

The first successful transplants of insulin-producing cells in people with type 1 diabetes occurred about 25 years ago. In recent years, advances once considered hypothetical, such as creating and ...